St Pancras Clinical Research was founded in 2016 by a group of medical experts with vast clinical trial experience across all phases – from ‘first-in-man’ studies, to post marketing.
SPCR has a particular interest in Gorlin Syndrome and other rare diseases, with a team of clinicians who have over 30 years of medical and research experience in the field.
We offer the opportunity to take part in clinical trials of new medicines for the treatment of Gorlin Syndrome, and our patients have access to a range of specialist facilities and in-house consultants.